The observed increase in peripheral inflammation in the present SPG11–HSP patient cohort is comparable to other neurodegenerative diseases, where the contribution of inflammation is well-established, supporting our findings of neuroinflammatory disease signatures in the limited postmortem tissue. The gene discussed is SPG11; the disease is neurodegenerative disease.